Cardinal Health, Inc. $CAH Shares Sold by Verdence Capital Advisors LLC

Key Points

• Verdence Capital Advisors LLC decreased its stake in Cardinal Health by 22.4%, now holding 15,080 shares valued at approximately $2.53 million.
• Insider Jessica L. Mayer sold 38,078 shares for about $5.67 million, representing a 44% reduction in her ownership.
• Analysts have issued a range of ratings for Cardinal Health, with a consensus average target price of $166 and most analysts rating the stock as a "Moderate Buy".

Verdence Capital Advisors LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 22.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,080 shares of the company's stock after selling 4,363 shares during the period. Verdence Capital Advisors LLC's holdings in Cardinal Health were worth $2,533,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Greykasell Wealth Strategies Inc. acquired a new stake in Cardinal Health in the first quarter valued at approximately $26,000. Jones Financial Companies Lllp boosted its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. GW&K Investment Management LLC raised its holdings in shares of Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after buying an additional 144 shares during the last quarter. Garde Capital Inc. purchased a new position in shares of Cardinal Health in the first quarter worth $52,000. Finally, Zions Bancorporation National Association UT purchased a new position in shares of Cardinal Health in the first quarter worth $52,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider owned 48,457 shares in the company, valued at $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer owned 26,085 shares in the company, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Leerink Partners raised their target price on shares of Cardinal Health from $186.00 to $187.00 and gave the stock an "outperform" rating in a report on Monday, October 6th. Wall Street Zen cut shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Morgan Stanley reissued an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $166.00.

Cardinal Health Stock Performance

CAH opened at $156.86 on Monday. Cardinal Health, Inc. has a fifty-two week low of $106.98 and a fifty-two week high of $168.44. The company has a fifty day moving average of $152.09 and a two-hundred day moving average of $151.31. The stock has a market capitalization of $37.27 billion, a price-to-earnings ratio of 24.32, a PEG ratio of 1.33 and a beta of 0.71.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. During the same quarter in the previous year, the company earned $1.84 earnings per share. The firm's revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health's dividend payout ratio (DPR) is 31.63%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.